Skip to Main Content

Author Details

Hao Huang
2010
30
21
PMIDPaper TitleJournal TitlePublished Year
36649564Targeting Microglial Metabolic Rewiring Synergizes with Immune-Checkpoint Blockade Therapy for Glioblastoma.Cancer Discov2023
36467341Single-cell transcriptome analysis of tumor immune microenvironment characteristics in colorectal cancer liver metastasis.Ann Transl Med2022
33821253COVID-19 infection in patients with connective tissue disease: A multicity study in Hubei province, China.2021
33472591Clinical characteristics of 14 COVID-19 deaths in Tianmen, China: a single-center retrospective study.BMC Infectious Diseases2021
33504324Correction to: Clinical characteristics of 14 COVID-19 deaths in Tianmen, China: a single-center retrospective study.BMC Infectious Diseases2021
30975912Homoharringtonine exhibits potent anti-tumor effect and modulates DNA epigenome in acute myeloid leukemia by targeting SP1/TET1/5hmC.Haematologica2020
32606006FTO-Dependent N [6]-Methyladenosine Modifications Inhibit Ovarian Cancer Stem Cell Self-Renewal by Blocking cAMP Signaling.Cancer Res2020
29775690Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities.Seminars in Cancer Biology2019
31623681HIF-1α contributes to Ang II-induced inflammatory cytokine production in podocytes.BMC pharmacology & toxicology2019
29633759Publisher Correction: miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia.Nat Commun2018
28017614FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N<sup>6</sup>-Methyladenosine RNA Demethylase.Cancer Cell2017
28500307ALOX5 exhibits anti-tumor and drug-sensitizing effects in MLL-rearranged leukemia.Scientific Reports2017
27116251miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia.Nat Commun2016
26747896PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.Cancer Res2016
26791235Identification of MLL-fusion/MYCâ¿£miR-26â¿£TET1 signaling circuit in MLL-rearranged leukemia.Cancer Lett2016
27280396Eradication of Acute Myeloid Leukemia with FLT3 Ligand-Targeted miR-150 Nanoparticles.Cancer Res2016
26361793Overexpression and knockout of miR-126 both promote leukemogenesis.Blood2015
23716660HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis.Proc Natl Acad Sci U S A2013
23818607TET1 plays an essential oncogenic role in MLL-rearranged leukemia.Proc Natl Acad Sci U S A2013
24336501The ginger-shaped asteroid 4179 Toutatis: new observations from a successful flyby of Chang'e-2.Scientific Reports2013
23798388miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia.Proc Natl Acad Sci U S A2013
23264595PBX3 is an important cofactor of HOXA9 in leukemogenesis.Blood2013
23382473Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study.J Clin Oncol2013
22251480Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML.Blood2012
22353710miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia.Nat Commun2012
22633751Two isoforms of HOXA9 function differently but work synergistically in human MLL-rearranged leukemia.Blood Cells Mol Dis2012
23132946MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia.Proc Natl Acad Sci U S A2012
23079661Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia.Cancer Cell2012
22238379Young intragenic miRNAs are less coexpressed with host genes than old ones: implications of miRNA-host gene coevolution.Nucleic Acids Res2012
20133587Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia.Proc Natl Acad Sci U S A2010
  • 1 - 30 of 30

Recommended Authors

Collaborators

Houston Methodist Hospital
Co-authored papers 18
National Human Genome Research Institute
Co-authored papers 12
Co-authored papers 6
Institute of Hematology, West China Hospital of Sichuan University
Co-authored papers 6
Yale University
Co-authored papers 4
Center for Biomedical Informatics and Biostatistics, University of Arizona
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Dana-Farber Cancer Institute
Co-authored papers 1
Co-authored papers 1
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Co-authored papers 1
Co-authored papers 1
IBM Thomas J Watson Research Center, University of California Los Angeles, University of North Carolina at Chapel Hill
Co-authored papers 1
Co-authored papers 1
the Children's Hospital Affiliated to Xi'an Jiaotong University
Co-authored papers 1
Center for Clinical and Translational Science, Rockefeller University
Co-authored papers 1
UPMC Hillman Cancer Center
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
The Chinese University of Hong Kong, Prince of Wales Hospital
Co-authored papers 1
The Wistar Institute
Co-authored papers 1
The Hospital for Sick Children
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1